Navidea Biopharmaceuticals Inc (NAVB) Gross Profit Margin starting from the third quarter 2023 to third quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Navidea Biopharmaceuticals Inc   (NAVB)


Navidea Biopharmaceuticals Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NAVB Gross Profit Margin (Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2023 Gross Profit Margin
Learn about Gross Margin
NAVB's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
100 % 83.72 % 18.54 %
(Dec 31 2020)   (Dec 31 2015)




Other Gross Profit Margin Profitability Ratios
NAVB's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NAVB's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NAVB's Competitors
Gross Profit Margin Profit Margin for Navidea Biopharmaceuticals Inc 's Suppliers
Gross Profit Margin Profit Margin for NAVB's Customers

You may also want to know
NAVB's Annual Growth Rates NAVB's Profitability Ratios NAVB's Asset Turnover Ratio NAVB's Dividend Growth
NAVB's Roe NAVB's Valuation Ratios NAVB's Financial Strength Ratios NAVB's Gross Profit Growth
NAVB's Roa NAVB's Inventory Turnover Ratio NAVB's Growth Rates NAVB's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2023, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginSep 30 2023 MRQ Gross ProfitSep 30 2023 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.